From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves everolimus for liver rejection

from MedPage Today

Everolimus has won FDA approval to prevent liver transplant rejection in adults, adding to its earlier similar approval in kidney transplant, according to the drug's manufacturer, Novartis. The approval is the first for an mTOR inhibitor in liver transplant, the company said. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063